MedTrace Logo

Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients

NCT00394927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2012-07-19

No results posted yet for this study

Summary

The purpose of the survey is to explore through a structured interview and patient examination the rate and distribution of neurological and systemic adverse effects related to antiepileptic treatment. Adverse effects and considerations to modify the therapy will be assessed in pediatric and adult patients with controlled as well as uncontrolled epilepsy with different seizure types

Conditions

Sponsors & Collaborators

  • International Bureau for Epilepsy

    collaborator OTHER

  • UCB Pharma

    lead INDUSTRY

Principal Investigators

  • Sonja Buyle, M.D. · UCB Pharma

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • Austria
  • Czechia
  • Germany
  • Italy
  • Poland
  • Romania
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00394927 on ClinicalTrials.gov